Press Release: Ferrow Pfanstiehl Laboratories : Pfanstiehl Launches New cGMP-produced, Parenteral Grade Maltose for Pharmaceutical Formulations

CHICAGO, Jan. 26, 2015 /PRNewswire-USNewswire/ -- Pfanstiehl has announced the launch of a new high purity, low endotoxin, Maltose (USP/NF, EP, JP), manufactured in the US under strict cGMP, ICH Q7 compliant conditions. "Maltose is a multifunctional disaccharide used to...